Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mareike Verbeek

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Science Immunology|January 28, 2022
Human skin-resident host T cells can persist long term after allogeneic stem cell transplantation and maintain recirculation potentialGustavo P de Almeida, Peter Lichtner, Gertrud Eckstein, et al.
Hemasphere|August 15, 2022
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From GermanyKrischan Braitsch, Laura K Schmalbrock, Paul Jung, et al.
Plos One|October 1, 2019
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapyBenjamin Faist, Fabian Schlott, Christian Stemberger, et al.
Bone Marrow Transplantation|April 23, 2024
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
Bone Marrow Transplantation|March 17, 2024
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
Theranostics|January 2, 2025
CXCR4-directed endoradiotherapy with [<sup>177</sup>Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemiaKrischan Braitsch, Theo Lorenzini, Maike Hefter, et al.
Vaccines|August 29, 2024
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine ResponseKrischan Braitsch, Samuel D Jeske, Jacob Stroh, et al.
Blood Advances|February 4, 2025
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantationAlessia Fraccaroli, Vindi Jurinovic, Klaus Hirschbühl, et al.
Blood|April 9, 2014
Activity of therapeutic JAK 1/2 blockade in graft-versus-host diseaseSilvia Spoerl, Nimitha R Mathew, Michael Bscheider, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Science Immunology|January 28, 2022
Human skin-resident host T cells can persist long term after allogeneic stem cell transplantation and maintain recirculation potentialGustavo P de Almeida, Peter Lichtner, Gertrud Eckstein, et al.
Hemasphere|August 15, 2022
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From GermanyKrischan Braitsch, Laura K Schmalbrock, Paul Jung, et al.
Plos One|October 1, 2019
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapyBenjamin Faist, Fabian Schlott, Christian Stemberger, et al.
Bone Marrow Transplantation|April 23, 2024
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
Bone Marrow Transplantation|March 17, 2024
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
Theranostics|January 2, 2025
CXCR4-directed endoradiotherapy with [<sup>177</sup>Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemiaKrischan Braitsch, Theo Lorenzini, Maike Hefter, et al.
Vaccines|August 29, 2024
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine ResponseKrischan Braitsch, Samuel D Jeske, Jacob Stroh, et al.
Blood Advances|February 4, 2025
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantationAlessia Fraccaroli, Vindi Jurinovic, Klaus Hirschbühl, et al.
Blood|April 9, 2014
Activity of therapeutic JAK 1/2 blockade in graft-versus-host diseaseSilvia Spoerl, Nimitha R Mathew, Michael Bscheider, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 7